Frontiers in Oncology | Cancer Immunity and Immunotherapy

Original Research

Accepted on 10 Apr 2025

Tumor-associated MerTK promotes a pro-inflammatory microenvironment and enhances immune checkpoint inhibitor response in triple-negative breast cancer

in Cancer Immunity and Immunotherapy

Bridget Crossman
Regan L Harmon
Mari Iida
Jillian M Adams
Candie Y Lin
Christine E Glitchev
Terry D Juang
Sheena Kerr
Roxana A Alexandridis
Meredith Hyun

Frontiers in Oncology

doi 10.3389/fonc.2025.1579214

Mini Review

Published on 09 Apr 2025

Activation-induced cytidine deaminase in tertiary lymphoid structures: dual roles and implications in cancer prognosis

in Cancer Immunity and Immunotherapy

Zhuangwei Lv
Junna Jiao
Wuyang Xue
Xiaoyu Shi
Ruihan Wang
Jinhua Wu

Frontiers in Oncology

doi 10.3389/fonc.2025.1555491

172 views

Mini Review

Published on 09 Apr 2025

Bispecific antibodies in immunotherapy for acute leukemia: latest updates from the 66th annual meeting of the American society of hematology, 2024

in Cancer Immunity and Immunotherapy

Weijie Cao
Shuhan Ma
Lijie Han
Hanzhou Xing
Yingmei Li
Zhongxing Jiang
Xuejun Guo
Jifeng Yu

Frontiers in Oncology

doi 10.3389/fonc.2025.1566202

159 views

Mini Review

Published on 09 Apr 2025

Single-cell RNA sequencing in diffuse large B-cell lymphoma: tumor heterogeneity, microenvironment, resistance, and prognostic markers

in Cancer Immunity and Immunotherapy

Linwei Li
Qiwei Li
Rui Niu
Wei Sun
Hua Liang

Frontiers in Oncology

doi 10.3389/fonc.2025.1583250

196 views

Brief Research Report

Published on 08 Apr 2025

Amyloid precursor-like protein 2 expression in macrophages: differentiation and M1/M2 macrophage dynamics

in Cancer Immunity and Immunotherapy

Gabrielle L. Brumfield
Shelby M. Knoche
Kenadie R. Doty
Alaina C. Larson
Brittany J. Poelaert
Don W. Coulter
Joyce C. Solheim

Frontiers in Oncology

doi 10.3389/fonc.2025.1570955

248 views

Editorial

Accepted on 07 Apr 2025

Editorial: The Tumor Microenvironment and Immunotherapy for Head and Neck Tumors

in Cancer Immunity and Immunotherapy

Yifan Jiang
Lei Tao

Frontiers in Oncology

doi 10.3389/fonc.2025.1606787

Editorial

Published on 07 Apr 2025

Editorial: Mitochondria in the regulation of anti-tumor immunity

in Cancer Immunity and Immunotherapy

Aqu Alu
Yang Wang
Yuan Cheng

Frontiers in Oncology

doi 10.3389/fonc.2025.1596146

157 views

Original Research

Accepted on 04 Apr 2025

Deciphering ERR Family Genes as Prognostic and Immunological Biomarkers through Pan-Cancer Analysis with Validation in Gallbladder Cancer

in Cancer Immunity and Immunotherapy

Wanwan Gong
Sijia Wen
Yu Chen
Fan Wu
Mengmeng Yang
Ping Sun
Xingmei Guo
Meiqin Li
Daozhen Chen
Hui Zhao

Frontiers in Oncology

doi 10.3389/fonc.2025.1525635

Case Report

Published on 03 Apr 2025

Case Report: Lasting complete response to pembrolizumab in mismatch repair-deficient cardiac sarcoma: a genomic characterization

in Cancer Immunity and Immunotherapy

Daniela A. Ferraro
Bettina Bisig
David C. Rotzinger
Fresia Pareja
Edoardo Missiaglia
Ioannis Voutsadakis
Krisztian Homicsko
Antonia Digklia

Frontiers in Oncology

doi 10.3389/fonc.2025.1485386

164 views

Review

Published on 03 Apr 2025

Combination therapy with oncolytic viruses for lung cancer treatment

in Cancer Immunity and Immunotherapy

Lei Sun
Qi Zhao
Liyun Miao

Frontiers in Oncology

doi 10.3389/fonc.2025.1524079

308 views

Case Report

Published on 01 Apr 2025

Emapalumab for severe cytokine release syndrome in solid tumor CAR-T: a case report

in Cancer Immunity and Immunotherapy

Tyler Ruemmele
Rodney Macedo
Mark N. Stein
Hei Ton Chan
Markus Y. Mapara
Céline F. Jacquemont
Ran Reshef

Frontiers in Oncology

doi 10.3389/fonc.2025.1543622

310 views

Mini Review

Accepted on 31 Mar 2025

Cell-Based Immunotherapies for Solid Tumors: Advances, Challenges, and Future Directions

in Cancer Immunity and Immunotherapy

Ting Zhao
Congyue Wang
Bo Li
Yuhan Liu
Wuyang Zhao
Chuang Zhou

Frontiers in Oncology

doi 10.3389/fonc.2025.1551583

Review

Accepted on 31 Mar 2025

Expanding horizons of cancer immunotherapy: hopes and hurdles

in Cancer Immunity and Immunotherapy

Priyanka Vijay Sonar
Anuj Kumar Singh
Sravan Mandadi
Prof. Nilesh Kumar Sharma

Frontiers in Oncology

doi 10.3389/fonc.2025.1511560

Review

Accepted on 31 Mar 2025

Rewiring Lipid Metabolism to Enhance Immunotherapy Efficacy in Melanoma: A Frontier in Cancer Treatment

in Cancer Immunity and Immunotherapy

Jian Cheng
Lihua Xiong

Frontiers in Oncology

doi 10.3389/fonc.2025.1519592

Review

Accepted on 28 Mar 2025

Nanoparticle-Mediated Delivery of Herbal-Derived Natural Products to Modulate Immunosenescence-Induced Drug Resistance in Cancer Therapy: A Comprehensive Review

in Cancer Immunity and Immunotherapy

Lichang Yang
Manman Xu

Frontiers in Oncology

doi 10.3389/fonc.2025.1567896

Case Report

Accepted on 27 Mar 2025

A rare case of sintilimab-induced dermatomyositis in a patient with gastric cancer

in Cancer Immunity and Immunotherapy

Peipei Mou
Fanghua Li
Feifei Zhao
Yingying Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1517391